Axya Medical Announces the Issuance of Patents for a Sutureless Fixation Device and a Sutureless Cardiac Valve Prosthesis.Business Editors and Health/Medical Writers BEVERLY, Mass.--(BW HealthWire)--June 7, 2000 Axya Medical Inc., a privately held medical device company, announced today that it has received notice from the U.S. Patent Office of the issuance of two patents. One patent covers a sutureless fixation device and the second is for a sutureless cardiac heart valve. CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Ken Fallon commented, "...these patents are another important step in the development of our intellectual property portfolio, which now includes seven significant patents with a number of applications in process at the U.S. Patent Office. The sutureless fixation device further expands our proprietary position in tissue fixation, which will lead to an exciting, innovative series of tissue anchor products. Our initial products will be used in sports medicine sports medicine, branch of medicine concerned with physical fitness and with the treatment and prevention of injuries and other disorders related to sports. Knee, leg, back, and shoulder injuries; stiffness and pain in joints; tendinitis; "tennis elbow"; and for rotator cuff rotator cuff n. A set of muscles and tendons that secures the arm to the shoulder joint and permits rotation of the arm. Also called musculotendinous cuff. repair in shoulder surgery. Additional opportunities exist in urology and urogynecology. The sutureless cardiac valve cardiac valve n. Any of the valves regulating the flow of blood through and from the heart, consisting of the aortic valve, the left and right atrioventricular valves, and the pulmonary valve. patent supports the application of our technology in cardiovascular surgery. We have been encouraged by the performance of Axya's ultrasonic technology in our cardiac valve development program. This work confirms the versatility of our technology and represents the achievement of a key milestone in our progress." Axya has developed a patented, proprietary method of utilizing ultrasonic energy to weld polymeric materials used in surgical procedures. Its initial products are designed to ultrasonically weld suture, thereby eliminating knot tying by the surgeon and knot impingement. These advantages are evident in the AxyaWeld(TM) System 1000, which is now being released for rotator cuff repair. AxyaWeld has been developed in collaboration with a number of leading sports medicine surgeons. This experience led to the conclusion that the elimination of knot tying through suture welding is a cost-effective alternative to what can be a time consuming, tedious task. Additional products are being developed for open and laparoscopic Laparoscopic A minimally-invasive surgical or diagnostic procedure that uses a flexible endoscope (laparoscope) to view and operate on structures in the abdomen. Mentioned in: Obstetrical Emergencies general surgical procedures Axya's institutional investors include Vector Fund Management and Marquette Venture Partners, both of Chicago, Illinois; Prism Venture Partners, Westwood, Massachusetts; US Bancorp Piper Jaffray, Minneapolis, Minnesota; Delphi Ventures, Menlo Park, California Menlo Park is a city in San Mateo County, California in the United States of America. It is located at latitude 37°29' North, longitude 122°9' East. Menlo Park had 30,785 inhabitants as of the 2000 U.S. Census. ; and Johnson & Johnson Development Corporation, New Brunswick, New Jersey This article is about the city in New Jersey. For the Canadian province, see New Brunswick. New Brunswick, also known as "the Healthcare City"[2] or "Hub City",[3] is a city and the county seat of the County of Middlesex, New Jersey, USA. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion